Robots for Cell Therapy manufacturing
ROBOTS manufacturing gene modified cell therapies to achieve industrial scale.


Key technology features
A unique, modular approach, to Cell Therapy automation that reduces manufacturing bottlenecks and minimizes human contamination.
Multiply Labs' robotic systems for cell therapy manufacturing are being developed in a Consortium with Cytiva, Thermo Fisher, Charles River Laboratories and UCSF.
To learn more, and to request a spot in our commercial deployment program, contact us.
Compatibility
Compatible with the market-leading GMP instruments
Bioreactor

Incubator

Testing


Each robotic module contains a single instrument; multiple modules are used together to automate a process
Flexibility
Any process can be implemented by selecting the corresponding combination of modules
Adaptable
It's easy to remove, add and swap modules

Parallelism (high-throughput)
A fully automated system where “fast” modules feed multiple parallel bioreactor modules
Recent News
WuXi STA and Multiply Labs announce partnership and successfully deploy robotic manufacturing system for personalized drugs Personalized doses can now be filled into single- or multi-compartment...
Load More